<p>PBMCs from allergic asthmatic subjects (n = 2) were stimulated with various concentrations of PHA (1 to 40 μg/mL) for 72 hours. Data is presented as mean ± SD.</p
SummaryObjectiveA well-controlled study in patients with allergic asthma was warranted to assess dos...
To test the hypothesis that some persistent organic pollutants contribute to the increased prevalenc...
The effect of omega-3 (n-3) in asthma has been inconclusive. One explanation for it may be the low i...
<p>Inhibition of cytokine release by 0 to 40 μg/ml of enoxaparin fractions 1 and 4. Cytokines [IL-4 ...
<p>Effect of different concentrations of enoxaparin and dalteparin on cytokine levels [IL-4 <b>(A)</...
<p><b>(A)</b> PHA-induced release of cytokines (logarithmic scale) from PBMCs of healthy (n = 5) and...
<p><b>(A)</b> Viability of PBMCs is presented as mean % LDH release ± SD from allergic asthmatic sub...
<p>PHA-induced release of IL-4, IL-5, IL-13 and TNF-α in PBMC culture supernatants of healthy (n = 1...
We investigated the effects of inhaled platelet-activating factor (PAF) on methacholine bronchial re...
<p>Neutrophils from allergic asthma patients were treated with an Ag to which the patient was sensit...
<p>All groups of asthmatics had a higher Lf levels than those of control subjects. Significant betwe...
<p>Change in levels of HNP1-3, LL-37, LCN2 and SLPI in nasal secretions from asthma patients and con...
To clarify whether thromboxane A(2) (TXA(2)) is involved in type III and IV allergy, so-called "cell...
<p><b>(A)</b> LDH activity of PBMC supernatants from asthmatic subjects (n = 5) expressed as the per...
<p>Suppression of TNF-α release by eight HP-SEC derived saccharides (dp2 to dp16) of enoxaparin <b>(...
SummaryObjectiveA well-controlled study in patients with allergic asthma was warranted to assess dos...
To test the hypothesis that some persistent organic pollutants contribute to the increased prevalenc...
The effect of omega-3 (n-3) in asthma has been inconclusive. One explanation for it may be the low i...
<p>Inhibition of cytokine release by 0 to 40 μg/ml of enoxaparin fractions 1 and 4. Cytokines [IL-4 ...
<p>Effect of different concentrations of enoxaparin and dalteparin on cytokine levels [IL-4 <b>(A)</...
<p><b>(A)</b> PHA-induced release of cytokines (logarithmic scale) from PBMCs of healthy (n = 5) and...
<p><b>(A)</b> Viability of PBMCs is presented as mean % LDH release ± SD from allergic asthmatic sub...
<p>PHA-induced release of IL-4, IL-5, IL-13 and TNF-α in PBMC culture supernatants of healthy (n = 1...
We investigated the effects of inhaled platelet-activating factor (PAF) on methacholine bronchial re...
<p>Neutrophils from allergic asthma patients were treated with an Ag to which the patient was sensit...
<p>All groups of asthmatics had a higher Lf levels than those of control subjects. Significant betwe...
<p>Change in levels of HNP1-3, LL-37, LCN2 and SLPI in nasal secretions from asthma patients and con...
To clarify whether thromboxane A(2) (TXA(2)) is involved in type III and IV allergy, so-called "cell...
<p><b>(A)</b> LDH activity of PBMC supernatants from asthmatic subjects (n = 5) expressed as the per...
<p>Suppression of TNF-α release by eight HP-SEC derived saccharides (dp2 to dp16) of enoxaparin <b>(...
SummaryObjectiveA well-controlled study in patients with allergic asthma was warranted to assess dos...
To test the hypothesis that some persistent organic pollutants contribute to the increased prevalenc...
The effect of omega-3 (n-3) in asthma has been inconclusive. One explanation for it may be the low i...
DOI
Add to ORKG